FDA Warns Clinics For Unlawful Advertising Of Allergan’s Lap-Band

Billboards and advertising inserts promoted the Lap-Band procedure without providing adequate risk information, FDA charges.

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Legal & IP

More from Policy & Regulation